Shermaine, who was aside, said, “It’s not like that. The allocation of spots for the clinical trials of Apothecary Pharmaceuticals is not based on who has money and power, but on who needs treatment the most. Those who sign up for the clinical trials are all cancer patients without exception. At least thirty percent of them have been declared by doctors to have less than six months to live. There are hundreds of patients with advanced pancreatic cancer alone, and many of them are children. Peopl